Literature DB >> 32949507

Psychedelic medicine: safety and ethical concerns.

Brian T Anderson1, Alicia L Danforth2, Charles S Grob3.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32949507     DOI： 10.1016/S2215-0366(20)30146-2

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  8 in total

Review 1.  Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

Authors:  David Bender; David J Hellerstein
Journal:  Psychopharmacology (Berl)       Date:  2022-01-13       Impact factor: 4.530

Review 2.  Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.

Authors:  Sean J Belouin; Lynnette A Averill; Jack E Henningfield; Stephen N Xenakis; Ingrid Donato; Charles S Grob; Ann Berger; Veronica Magar; Alicia L Danforth; Brian T Anderson
Journal:  Neuropharmacology       Date:  2022-08-13       Impact factor: 5.273

Review 3.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

4.  Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Authors:  William E Rosa; Zachary Sager; Megan Miller; Ilan Bernstein; Alden Doerner Rinaldi; Katie Addicott; Michael Ljuslin; Chris Adrian; Anthony L Back; Jamie Beachy; Anthony P Bossis; William S Breitbart; Mary P Cosimano; Stacy M Fischer; Jeffrey Guss; Emma Knighton; Janis Phelps; Brian D Richards; William A Richards; James A Tulsky; Monnica T Williams; Yvan Beaussant
Journal:  J Palliat Med       Date:  2022-03-14       Impact factor: 2.947

5.  Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field.

Authors:  Franklin King; Rebecca Hammond
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-06-17

6.  Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.

Authors:  Brian T Anderson; Alicia Danforth; Prof Robert Daroff; Christopher Stauffer; Eve Ekman; Gabrielle Agin-Liebes; Alexander Trope; Matthew Tyler Boden; Prof James Dilley; Jennifer Mitchell; Joshua Woolley
Journal:  EClinicalMedicine       Date:  2020-09-24

7.  Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.

Authors:  Yvan Beaussant; James Tulsky; Benjamin Guérin; Claudia Schwarz-Plaschg; Justin J Sanders
Journal:  J Palliat Med       Date:  2021-04-13       Impact factor: 2.947

8.  Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model.

Authors:  William Brennan; Alexander B Belser
Journal:  Front Psychol       Date:  2022-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.